0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover278.27%IV81.16%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.1695Delta0.1239Gamma27.60Leverage Ratio-0.0225Theta0.0002Rho4.68Eff Leverage0.0019Vega
Sophia Genetics Stock Discussion
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
SOPHiA GENETICS (Nasdaq: SOPH) announced a collaboration with Microsoft and NVIDIA to launch a whole genome sequencing (WGS) analytical solution by end of 2024. The new WGS application aims to deliver fully analyzed genome insights within the same day, enhancing research, drug discovery, and clinical care. Leveraging Microsoft Azure and NVIDIA Parabricks, the solution will provide scalable and rapid...
NEWS
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
Unilabs, a leading diagnostic provider in Europe, has implemented SOPHiA GENETICS' AI technology for HRD testing in solid tumors across its network in Switzerland. HRD, a common alteration in ovarian cancer, affects approximately half of newly diagnosed patients, making it a important factor in treatment planning. SOPHiA GENETICS' SOPHiA DDM™ Platform u...
SOPHiA GENETICS (SOPH) partners with Strand Life Sciences to advance precision medicine globally. The collaboration aims to provide innovative solutions leveraging genomics technologies and bioinformatics services.
No comment yet